Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson's Disease
Clinical trial NCT05094050 · COMPLETED
Trial details
- NCT number
- NCT05094050
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-18
- Primary completion
- 2023-03-17
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.